GlassScriptPhysician profile
Eric G Halvorson
NPI 1316963879
$3,603.20
in general payments reported to CMS, 2019-2025
19 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $761 · 2020: $85.21 · 2021: $271 · 2022: $564 · 2023: $750 · 2024: $972 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,596 · Long Term Medical Supply Or Device Loan: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,596.47 |
| Long Term Medical Supply Or Device Loan | $325.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $1,452.89 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Memorygel Breast Implant |
| Sientra, INC. | $399.93 | 2021-2022 | |
| Integra Lifesciences Corporation | $382.46 | 2023-2024 | Durasorb Monofilament Mesh, Integra, Surgimend |
| Galderma Laboratories, L.P. | $202.10 | 2019-2023 | |
| Vertex Pharmaceuticals Incorporated | $168.26 | 2024-2025 | |
| Abbvie INC. | $158.41 | 2023-2025 | |
| Tela Bio, INC. | $148.35 | 2022 | |
| Vioptix INC | $146.64 | 2019-2023 | |
| Tepha INC | $142.14 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $84.73 | 2019-2024 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $69.42 | 2019 | |
| Davol INC. | $58.65 | 2021-2022 | |
| Allergan, INC. | $49.92 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $39.44 | 2020 | |
| Coopersurgical, INC. | $33.00 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $22.77 | 2025 | Novosorb Btm |
| Kci USA, INC. | $17.49 | 2021 | |
| Covidien LP | $13.83 | 2019 | |
| Smith+Nephew, INC. | $12.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Halvorson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.